Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Multiple Myeloma Research and Treatments, and Lung Cancer Treatments and Mutations.
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies
Human genomic DNA is widely interspersed with i-motif structures
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
Neoantigen-directed immune escape in lung cancer evolution
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
Enhanced cross‐priming of naive <scp>CD</scp>8<sup>+</sup><scp>T</scp> cells by dendritic cells treated by the <scp>IM</scp>i<scp>D</scp>s<sup>®</sup> immunomodulatory compounds lenalidomide and pomalidomide